一家25年biotech:换CEO,放弃细胞疗法

生物药大时代
15 May

2025 未来医药新物种百强奖 FNS101| 点击查看详情近日,一家成立了25年的比利时生物技术公司 Galapagos NV宣布:换CEO(首席执行官)、放弃细胞疗法,原本分拆公司上市计划全变。这家公司也是神奇般的存在,1999年成立,2005 年在布鲁塞尔和阿姆斯特丹泛欧交易所上市,2015 年在纳斯达克上市,目前市值为16.7亿美元。成立至今25年,却未有一款疗法获批。原本,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10